186
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Serum Uric Acid to Creatinine Ratio and Risk of Metabolic Syndrome in Patients with Overweight/Obesity

, , ORCID Icon, , , ORCID Icon, , , , , & ORCID Icon show all
Pages 3007-3017 | Received 21 Jun 2023, Accepted 21 Sep 2023, Published online: 28 Sep 2023

References

  • Grundy S, Cleeman J, Daniels S, et al. Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circ. 2005;112(17):2735–2752. doi:10.1161/CIRCULATIONAHA.105.169404
  • Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006;119(10):812–819. doi:10.1016/j.amjmed.2006.02.031
  • Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med. 2004;140(3):167–174. doi:10.7326/0003-4819-140-3-200402030-00007
  • Cleeman J, Grundy S, Becker D, et al.; Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults E. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486–2497. doi:10.1001/jama.285.19.2486
  • Ibrahim MS, Pang D, Randhawa G, Pappas Y. Risk models and scores for metabolic syndrome: systematic review protocol. BMJ OPEN. 2019;9(9). doi:10.1136/bmjopen-2018-027326
  • Gu D, Reynolds K, Wu X, et al. Prevalence of the metabolic syndrome and overweight among adults in China. LANCET. 2005;365(9468):1398–1405. doi:10.1016/S0140-6736(05)66375-1
  • Xie J, Zu Y, Alkhatib A, et al. Metabolic syndrome and COVID-19 mortality among adult black patients in New Orleans. DIABETES CARE. 2021;44(1):188–193. doi:10.2337/dc20-1714
  • Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20(2):. doi:10.1007/s11906-018-0812-z
  • Hirode G, Wong R. Trends in the prevalence of metabolic syndrome in the United States, 2011–2016. JAMA. 2020;323(24):2526–2528. doi:10.1001/jama.2020.4501
  • Ranasinghe P, Mathangasinghe Y, Jayawardena R, Hills AP, Misra A. Prevalence and trends of metabolic syndrome among adults in the Asia-pacific region: a systematic review. BMC Public Health. 2017;17. doi:10.1186/s12889-017-4041-1
  • Yao F, Bo Y, Zhao L, et al. Prevalence and influencing factors of metabolic syndrome among adults in China from 2015 to 2017. NUTRIENTS. 2021;13(12):4475. doi:10.3390/nu13124475
  • Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V. Regulation of uric acid metabolism and excretion. Int J Cardiol. 2016;213:8–14. doi:10.1016/j.ijcard.2015.08.109
  • Zoppini G, Targher G, Chonchol M, et al. Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function. Diabetes Care. 2012;35(1):99–104. doi:10.2337/dc11-1346
  • Sturm G, Kollerits B, Neyer U, Ritz E, Kronenberg F. MMKD study grp. Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study. Exp Gerontol. 2008;43(4):347–352. doi:10.1016/j.exger.2008.01.006
  • Culleton B, Larson M, Kannel W, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med. 1999;131(1):7. doi:10.7326/0003-4819-131-1-199907060-00003
  • Mangge H, Zelzer S, Puerstner P, et al. Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults. Obesity. 2013;21(1):E71–E77. doi:10.1002/oby.20061
  • Zhang H, Li Y, Mao Z, et al. Sex-specific associations of serum uric acid with metabolic syndrome in Chinese rural population: the RuralDiab study. Clin Chim Acta. 2018;480:119–125. doi:10.1016/j.cca.2018.02.003
  • Ford E, Li C, Cook S, Choi H. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circ. 2007;115(19):2526–2532. doi:10.1161/CIRCULATIONAHA.106.657627
  • Yadav D, Lee ES, Kim HM, et al. Prospective study of serum uric acid levels and incident metabolic syndrome in a Korean rural cohort. Atherosclerosis. 2015;241(1):271–277. doi:10.1016/j.atherosclerosis.2015.04.797
  • Liu N, Xu H, Sun Q, et al. The role of oxidative stress in hyperuricemia and Xanthine Oxidoreductase (XOR) inhibitors. Oxid Med Cell Longev. 2021;2021:1–15. doi:10.1155/2021/1470380
  • Jakubiak GK, Osadnik K, Lejawa M, et al. “Obesity and insulin resistance” Is the component of the metabolic syndrome most strongly associated with oxidative stress. Antioxidants. 2021;11(1):79. doi:10.3390/antiox11010079
  • Li L, Song Q, Yang X. Lack of associations between elevated serum uric acid and components of metabolic syndrome such as hypertension, dyslipidemia, and T2DM in overweight and obese Chinese adults. J Diabetes Res. 2019;2019:1–8. doi:10.1155/2019/3175418
  • Ferrara LA, Wang H, Umans JG, et al. Serum uric acid does not predict incident metabolic syndrome in a population with high prevalence of obesity. Nutr Metab Cardiovasc Dis. 2014;24(12):1360–1364. doi:10.1016/j.numecd.2014.06.002
  • Gu L, Huang L, Wu H, Lou Q, Bian R. Serum uric acid to creatinine ratio: a predictor of incident chronic kidney disease in type 2 diabetes mellitus patients with preserved kidney function. Diabetes Vasc Dis Res. 2017;14(3):221–225. doi:10.1177/1479164116680318
  • Wang A, Tian X, Wu S, et al. Metabolic factors mediate the association between serum uric acid to serum creatinine ratio and cardiovascular disease. J Am Heart Assoc. 2021;10(23). doi:10.1161/JAHA.121.023054
  • Zhong D, Liu D, Guo Y, et al. Association of the serum uric acid to creatinine ratio with metabolic syndrome in the middle age and older population in China. Front Endocrinol (Lausanne). 2022;13:1060442. doi:10.3389/fendo.2022.1060442
  • Al-Daghri NM, Al-Attas OS, Wani K, Sabico S, Alokail MS. Serum uric acid to creatinine ratio and risk of metabolic syndrome in Saudi Type 2 diabetic patients. Sci Rep. 2017;7(1). doi:10.1038/s41598-017-12085-0
  • Wang Y, Mi J, Shan X-Y, Wang QJ, Ge K-Y. Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes. 2007;31(1):177–188. doi:10.1038/s41598-017-12085-0
  • Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130(6):461. doi:10.7326/0003-4819-130-6-199903160-00002
  • Pang C, Jia L, Hou X, et al. The significance of screening for microvascular diseases in Chinese community-based subjects with various metabolic abnormalities. PLoS One. 2014;9(5). doi:10.1371/journal.pone.0097928
  • Edwards NL. The role of hyperuricemia and gout in kidney and cardiovascular disease. Cleve Clin J Med. 2008;75 Suppl 5:S13–6. doi:10.3949/ccjm.75.Suppl_5.S13
  • Li M, Gu L, Yang J, Lou Q. Serum uric acid to creatinine ratio correlates with β-cell function in type 2 diabetes. Diabetes/Metab Res Rev. 2018;34(5). doi:10.1002/dmrr.3001
  • Kawamoto R, Ninomiya D, Kikuchi A, et al. Serum uric acid to creatinine ratio is a useful predictor of renal dysfunction among diabetic persons. Diabetes Metab Syndr Clinc Res Rev. 2019;13(3):1851–1856. doi:10.1016/j.dsx.2019.04.023
  • Kawamoto R, Kikuchi A, Ninomiya D, Tokumoto Y, Kumagi T. Serum uric acid to creatinine ratio is a useful predictor of all-cause mortality among hypertensive patients. Clin Hypertens. 2023;29(1). doi:10.1186/s40885-023-00235-8
  • Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766–781. doi:10.1016/S0140-6736(14)60460-8
  • Ritchie SA, Connell JMC. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis. 2007;17(4):319–326. doi:10.1016/j.numecd.2006.07.005
  • Choi Y-J, Yoon Y, Lee K-Y, et al. Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis. FASEB J. 2014;28(7):3197–3204. doi:10.1096/fj.13-247148
  • Nakagawa T, Hu HB, Zharikov S, et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol-Renal Physiol. 2006;290(3):F625–F631. doi:10.1152/ajprenal.00140.2005
  • Krzystek-Korpacka M, Patryn E, Kustrzeba-Wojcicka I, Chrzanowska J, Gamian A, Noczynska A. Gender-specific association of serum uric acid with metabolic syndrome and its components in juvenile obesity. Clin Chem Lab Med. 2011;49(1):129–136. doi:10.1515/CCLM.2011.011
  • Johnson RJ, Nakagawa T, Gabriela Sanchez-Lozada L, et al. Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes. 2013;62(10):3307–3315. doi:10.2337/db12-1814
  • Facchini F. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA. 1991;266(21):3008–3011. doi:10.1152/ajprenal.00140.2005